These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6721466)

  • 21. Susceptibility of anaerobic bacteria to meropenem.
    Nord CE; Lindmark A; Persson I
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():113-7. PubMed ID: 2553656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1649-54. PubMed ID: 8215278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Susceptibility of strict anaerobic bacteria to antibiotics in France: a multicenter study].
    Grollier G; Mory F; Quentin C; Girard-Pipau F; Tigaud S; Sedallian A; Dubreuil L
    Pathol Biol (Paris); 1994 May; 42(5):498-504. PubMed ID: 7824321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of anaerobic bacteria to PD 131628.
    Nord CE; Hagelbäck A
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):68-71. PubMed ID: 1314176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of cefbuperazone, a new cephamycin, against anaerobic bacteria.
    Prabhala RH; Thadepalli H; Rao B; Bansal MB; Marshall R
    Antimicrob Agents Chemother; 1985 Apr; 27(4):640-2. PubMed ID: 4004195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of L-627 against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):757-60. PubMed ID: 1425740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg.
    van der Westhuyzen I; Chalkley LJ
    S Afr Med J; 1992 Nov; 82(5):314-7. PubMed ID: 1448710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of telithromycin (HMR 3647) and seven other antimicrobial agents against anaerobic bacteria.
    Ackermann G; Schaumann R; Pless B; Claros MC; Rodloff AC
    J Antimicrob Chemother; 2000 Jul; 46(1):115-9. PubMed ID: 10882699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1984 Mar; 25(3):319-26. PubMed ID: 6232895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European collaborative study of reproducibility of quantitative sensitivity testing of anaerobes.
    King A; Phillips I
    J Antimicrob Chemother; 1988 Apr; 21(4):425-38. PubMed ID: 3378957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin].
    Dubreuil L; Derriennic M; Reynaud A; Devos J; Romond C; Courtieu A
    Pathol Biol (Paris); 1985 Nov; 33(9):899-903. PubMed ID: 3909082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):640-2. PubMed ID: 8223667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.
    Dornbusch K; Nord CE; Olsson-Liljeqvist B
    Scand J Infect Dis Suppl; 1979; (19):17-25. PubMed ID: 37593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting the in vitro activity of cefoperazone against the Bacteroides fragilis group.
    Sutter VL; Kwok YY
    Antimicrob Agents Chemother; 1981 Dec; 20(6):723-5. PubMed ID: 6459765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative activity of ciprofloxacin against anaerobic bacteria.
    Sutter VL; Kwok YY; Bulkacz J
    Antimicrob Agents Chemother; 1985 Mar; 27(3):427-8. PubMed ID: 3158278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of anaerobic bacteria to tosufloxacin.
    Nord CE; Lindmark A; Persson I; Runow C
    Eur J Clin Microbiol Infect Dis; 1992 Mar; 11(3):263-5. PubMed ID: 1597207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro effect of piperacillin, amoxicillin, cefoxitin and metronidazole against obligate anaerobic bacteria].
    Derriennic M; Reynaud A; Launay C; Courtieu AL
    Presse Med; 1986 Dec; 15(46):2279-81. PubMed ID: 2949268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.
    Bansal MB; Thadepalli H
    Antimicrob Agents Chemother; 1987 Apr; 31(4):619-21. PubMed ID: 3606066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative effect of apalcillin and other beta-lactam antibiotics against the Bacteroides fragilis group].
    Dusart G; Simeon de Buochberg M; Zuccarelli M; Attisso MA; Willemin C
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):523-7. PubMed ID: 2797878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.